nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—CYP1A2—Dacarbazine—muscle cancer	0.114	0.226	CbGbCtD
Bromocriptine—ABCB1—Dactinomycin—muscle cancer	0.0864	0.171	CbGbCtD
Bromocriptine—CYP1A2—Etoposide—muscle cancer	0.0557	0.11	CbGbCtD
Bromocriptine—ABCB1—Vincristine—muscle cancer	0.0532	0.105	CbGbCtD
Bromocriptine—ABCB1—Etoposide—muscle cancer	0.0487	0.0966	CbGbCtD
Bromocriptine—ABCB1—Doxorubicin—muscle cancer	0.0332	0.0659	CbGbCtD
Bromocriptine—ABCB1—Methotrexate—muscle cancer	0.0322	0.0638	CbGbCtD
Bromocriptine—CYP3A4—Vincristine—muscle cancer	0.0319	0.0632	CbGbCtD
Bromocriptine—CYP3A4—Etoposide—muscle cancer	0.0292	0.0579	CbGbCtD
Bromocriptine—CYP3A4—Doxorubicin—muscle cancer	0.0199	0.0395	CbGbCtD
Bromocriptine—Fibrosis—Methotrexate—muscle cancer	0.00678	0.0157	CcSEcCtD
Bromocriptine—Taste metallic—Methotrexate—muscle cancer	0.0061	0.0141	CcSEcCtD
Bromocriptine—Abdominal cramps—Vincristine—muscle cancer	0.00592	0.0137	CcSEcCtD
Bromocriptine—Diabetic—Methotrexate—muscle cancer	0.00581	0.0134	CcSEcCtD
Bromocriptine—Neurotoxicity—Methotrexate—muscle cancer	0.005	0.0116	CcSEcCtD
Bromocriptine—Numbness—Vincristine—muscle cancer	0.00482	0.0111	CcSEcCtD
Bromocriptine—Pericardial effusion—Methotrexate—muscle cancer	0.00472	0.0109	CcSEcCtD
Bromocriptine—Sensory loss—Vincristine—muscle cancer	0.00461	0.0107	CcSEcCtD
Bromocriptine—Pericarditis—Methotrexate—muscle cancer	0.00448	0.0104	CcSEcCtD
Bromocriptine—Pulmonary fibrosis—Methotrexate—muscle cancer	0.00441	0.0102	CcSEcCtD
Bromocriptine—Neurotoxicity—Doxorubicin—muscle cancer	0.00433	0.01	CcSEcCtD
Bromocriptine—Lung infiltration—Methotrexate—muscle cancer	0.00413	0.00955	CcSEcCtD
Bromocriptine—Pericardial effusion—Doxorubicin—muscle cancer	0.00409	0.00945	CcSEcCtD
Bromocriptine—Tingling sensation—Etoposide—muscle cancer	0.00403	0.0093	CcSEcCtD
Bromocriptine—Laboratory test abnormal—Doxorubicin—muscle cancer	0.00402	0.00928	CcSEcCtD
Bromocriptine—Numbness—Etoposide—muscle cancer	0.0039	0.00902	CcSEcCtD
Bromocriptine—Pericarditis—Doxorubicin—muscle cancer	0.00388	0.00897	CcSEcCtD
Bromocriptine—HTR2A—hindlimb—muscle cancer	0.00376	0.0601	CbGeAlD
Bromocriptine—Sensory loss—Etoposide—muscle cancer	0.00374	0.00863	CcSEcCtD
Bromocriptine—Lethargy—Dactinomycin—muscle cancer	0.00331	0.00765	CcSEcCtD
Bromocriptine—HTR2A—appendage—muscle cancer	0.00323	0.0516	CbGeAlD
Bromocriptine—Dysphagia—Dactinomycin—muscle cancer	0.00281	0.00648	CcSEcCtD
Bromocriptine—Burning sensation—Methotrexate—muscle cancer	0.00279	0.00645	CcSEcCtD
Bromocriptine—Urinary retention—Vincristine—muscle cancer	0.00276	0.00637	CcSEcCtD
Bromocriptine—Ataxia—Vincristine—muscle cancer	0.00273	0.0063	CcSEcCtD
Bromocriptine—DRD4—testis—muscle cancer	0.00267	0.0427	CbGeAlD
Bromocriptine—Cardiac failure congestive—Etoposide—muscle cancer	0.00259	0.00598	CcSEcCtD
Bromocriptine—Pleural effusion—Methotrexate—muscle cancer	0.00253	0.00585	CcSEcCtD
Bromocriptine—Burning sensation—Doxorubicin—muscle cancer	0.00242	0.00558	CcSEcCtD
Bromocriptine—Dermatitis atopic—Doxorubicin—muscle cancer	0.00227	0.00524	CcSEcCtD
Bromocriptine—ADRA1B—renal system—muscle cancer	0.00223	0.0357	CbGeAlD
Bromocriptine—Acute coronary syndrome—Vincristine—muscle cancer	0.0022	0.00509	CcSEcCtD
Bromocriptine—Pleural effusion—Doxorubicin—muscle cancer	0.00219	0.00506	CcSEcCtD
Bromocriptine—Myocardial infarction—Vincristine—muscle cancer	0.00219	0.00506	CcSEcCtD
Bromocriptine—Amblyopia—Doxorubicin—muscle cancer	0.00217	0.00502	CcSEcCtD
Bromocriptine—Cramp muscle—Etoposide—muscle cancer	0.00212	0.00489	CcSEcCtD
Bromocriptine—Dysphagia—Etoposide—muscle cancer	0.00203	0.00469	CcSEcCtD
Bromocriptine—Hallucination—Vincristine—muscle cancer	0.002	0.00461	CcSEcCtD
Bromocriptine—Hypoaesthesia—Vincristine—muscle cancer	0.002	0.00461	CcSEcCtD
Bromocriptine—Vasculitis—Methotrexate—muscle cancer	0.00199	0.00459	CcSEcCtD
Bromocriptine—Alopecia—Dactinomycin—muscle cancer	0.00198	0.00458	CcSEcCtD
Bromocriptine—Connective tissue disorder—Vincristine—muscle cancer	0.00197	0.00455	CcSEcCtD
Bromocriptine—Delirium—Doxorubicin—muscle cancer	0.00195	0.00451	CcSEcCtD
Bromocriptine—DRD3—head—muscle cancer	0.00195	0.0311	CbGeAlD
Bromocriptine—HTR6—head—muscle cancer	0.00187	0.0299	CbGeAlD
Bromocriptine—Cardiac disorder—Vincristine—muscle cancer	0.00186	0.0043	CcSEcCtD
Bromocriptine—DRD5—head—muscle cancer	0.00182	0.0291	CbGeAlD
Bromocriptine—Angiopathy—Vincristine—muscle cancer	0.00182	0.00421	CcSEcCtD
Bromocriptine—Mediastinal disorder—Vincristine—muscle cancer	0.00181	0.00418	CcSEcCtD
Bromocriptine—Dyskinesia—Doxorubicin—muscle cancer	0.00179	0.00413	CcSEcCtD
Bromocriptine—Acute coronary syndrome—Etoposide—muscle cancer	0.00178	0.00412	CcSEcCtD
Bromocriptine—Myocardial infarction—Etoposide—muscle cancer	0.00177	0.0041	CcSEcCtD
Bromocriptine—Alopecia—Vincristine—muscle cancer	0.00177	0.0041	CcSEcCtD
Bromocriptine—Mental disorder—Vincristine—muscle cancer	0.00176	0.00406	CcSEcCtD
Bromocriptine—Ventricular tachycardia—Doxorubicin—muscle cancer	0.00168	0.00388	CcSEcCtD
Bromocriptine—Diabetes mellitus—Methotrexate—muscle cancer	0.00162	0.00374	CcSEcCtD
Bromocriptine—Hypoaesthesia—Etoposide—muscle cancer	0.00162	0.00374	CcSEcCtD
Bromocriptine—Agitation—Vincristine—muscle cancer	0.0016	0.00371	CcSEcCtD
Bromocriptine—Oedema—Dactinomycin—muscle cancer	0.0016	0.00369	CcSEcCtD
Bromocriptine—Infection—Dactinomycin—muscle cancer	0.00158	0.00366	CcSEcCtD
Bromocriptine—HTR2B—smooth muscle tissue—muscle cancer	0.00158	0.0252	CbGeAlD
Bromocriptine—Vertigo—Vincristine—muscle cancer	0.00157	0.00363	CcSEcCtD
Bromocriptine—Cramps of lower extremities—Doxorubicin—muscle cancer	0.00154	0.00356	CcSEcCtD
Bromocriptine—Anorexia—Dactinomycin—muscle cancer	0.00152	0.00351	CcSEcCtD
Bromocriptine—Eye disorder—Etoposide—muscle cancer	0.00152	0.00351	CcSEcCtD
Bromocriptine—Convulsion—Vincristine—muscle cancer	0.00151	0.0035	CcSEcCtD
Bromocriptine—Cardiac disorder—Etoposide—muscle cancer	0.00151	0.00348	CcSEcCtD
Bromocriptine—Hypertension—Vincristine—muscle cancer	0.00151	0.00348	CcSEcCtD
Bromocriptine—ADRA1B—head—muscle cancer	0.00149	0.0239	CbGeAlD
Bromocriptine—Visual disturbance—Methotrexate—muscle cancer	0.00148	0.00343	CcSEcCtD
Bromocriptine—Angiopathy—Etoposide—muscle cancer	0.00147	0.00341	CcSEcCtD
Bromocriptine—Mediastinal disorder—Etoposide—muscle cancer	0.00146	0.00338	CcSEcCtD
Bromocriptine—ADRA1D—head—muscle cancer	0.00146	0.0233	CbGeAlD
Bromocriptine—Alopecia—Etoposide—muscle cancer	0.00144	0.00332	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Methotrexate—muscle cancer	0.00144	0.00332	CcSEcCtD
Bromocriptine—Lethargy—Methotrexate—muscle cancer	0.00144	0.00332	CcSEcCtD
Bromocriptine—Oedema—Vincristine—muscle cancer	0.00143	0.00329	CcSEcCtD
Bromocriptine—ADRB1—cardiac atrium—muscle cancer	0.00142	0.0227	CbGeAlD
Bromocriptine—Infection—Vincristine—muscle cancer	0.00142	0.00327	CcSEcCtD
Bromocriptine—Diabetes mellitus—Doxorubicin—muscle cancer	0.0014	0.00324	CcSEcCtD
Bromocriptine—Nervous system disorder—Vincristine—muscle cancer	0.0014	0.00323	CcSEcCtD
Bromocriptine—DRD1—head—muscle cancer	0.00139	0.0222	CbGeAlD
Bromocriptine—Decreased appetite—Dactinomycin—muscle cancer	0.00139	0.0032	CcSEcCtD
Bromocriptine—Dysgeusia—Etoposide—muscle cancer	0.00139	0.0032	CcSEcCtD
Bromocriptine—Fatigue—Dactinomycin—muscle cancer	0.00138	0.00318	CcSEcCtD
Bromocriptine—HTR1A—renal system—muscle cancer	0.00136	0.0217	CbGeAlD
Bromocriptine—Muscle spasms—Etoposide—muscle cancer	0.00136	0.00314	CcSEcCtD
Bromocriptine—Anorexia—Vincristine—muscle cancer	0.00136	0.00314	CcSEcCtD
Bromocriptine—HTR7—smooth muscle tissue—muscle cancer	0.00135	0.0216	CbGeAlD
Bromocriptine—Cardiac failure congestive—Doxorubicin—muscle cancer	0.00134	0.0031	CcSEcCtD
Bromocriptine—Hypotension—Vincristine—muscle cancer	0.00133	0.00308	CcSEcCtD
Bromocriptine—Ataxia—Methotrexate—muscle cancer	0.00132	0.00306	CcSEcCtD
Bromocriptine—Feeling abnormal—Dactinomycin—muscle cancer	0.00131	0.00304	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.0013	0.00301	CcSEcCtD
Bromocriptine—HTR7—renal system—muscle cancer	0.0013	0.0208	CbGeAlD
Bromocriptine—Insomnia—Vincristine—muscle cancer	0.00129	0.00298	CcSEcCtD
Bromocriptine—Paraesthesia—Vincristine—muscle cancer	0.00128	0.00296	CcSEcCtD
Bromocriptine—Vertigo—Etoposide—muscle cancer	0.00127	0.00294	CcSEcCtD
Bromocriptine—Body temperature increased—Dactinomycin—muscle cancer	0.00126	0.00291	CcSEcCtD
Bromocriptine—Abdominal pain—Dactinomycin—muscle cancer	0.00126	0.00291	CcSEcCtD
Bromocriptine—ADRA1A—renal system—muscle cancer	0.00126	0.02	CbGeAlD
Bromocriptine—Hypoglycaemia—Doxorubicin—muscle cancer	0.00125	0.00288	CcSEcCtD
Bromocriptine—Loss of consciousness—Etoposide—muscle cancer	0.00124	0.00287	CcSEcCtD
Bromocriptine—Cerebrovascular accident—Doxorubicin—muscle cancer	0.00124	0.00287	CcSEcCtD
Bromocriptine—Lethargy—Doxorubicin—muscle cancer	0.00124	0.00287	CcSEcCtD
Bromocriptine—Decreased appetite—Vincristine—muscle cancer	0.00124	0.00286	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Vincristine—muscle cancer	0.00123	0.00284	CcSEcCtD
Bromocriptine—Fatigue—Vincristine—muscle cancer	0.00123	0.00284	CcSEcCtD
Bromocriptine—Convulsion—Etoposide—muscle cancer	0.00123	0.00283	CcSEcCtD
Bromocriptine—Hypertension—Etoposide—muscle cancer	0.00122	0.00282	CcSEcCtD
Bromocriptine—Constipation—Vincristine—muscle cancer	0.00122	0.00282	CcSEcCtD
Bromocriptine—Diplopia—Doxorubicin—muscle cancer	0.00122	0.00281	CcSEcCtD
Bromocriptine—Gastrointestinal haemorrhage—Doxorubicin—muscle cancer	0.00122	0.00281	CcSEcCtD
Bromocriptine—ADRA2C—renal system—muscle cancer	0.0012	0.0191	CbGeAlD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.0012	0.00276	CcSEcCtD
Bromocriptine—HTR2B—tendon—muscle cancer	0.00119	0.0189	CbGeAlD
Bromocriptine—Abdominal discomfort—Methotrexate—muscle cancer	0.00117	0.00269	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Vincristine—muscle cancer	0.00117	0.00269	CcSEcCtD
Bromocriptine—Confusional state—Etoposide—muscle cancer	0.00116	0.00269	CcSEcCtD
Bromocriptine—Infection—Etoposide—muscle cancer	0.00115	0.00265	CcSEcCtD
Bromocriptine—Ataxia—Doxorubicin—muscle cancer	0.00115	0.00265	CcSEcCtD
Bromocriptine—Asthenia—Dactinomycin—muscle cancer	0.00114	0.00264	CcSEcCtD
Bromocriptine—HTR1B—head—muscle cancer	0.00113	0.018	CbGeAlD
Bromocriptine—Tachycardia—Etoposide—muscle cancer	0.00113	0.0026	CcSEcCtD
Bromocriptine—Abdominal pain—Vincristine—muscle cancer	0.00113	0.0026	CcSEcCtD
Bromocriptine—Body temperature increased—Vincristine—muscle cancer	0.00113	0.0026	CcSEcCtD
Bromocriptine—Skin disorder—Etoposide—muscle cancer	0.00112	0.00259	CcSEcCtD
Bromocriptine—Orthostatic hypotension—Doxorubicin—muscle cancer	0.00111	0.00257	CcSEcCtD
Bromocriptine—Abdominal pain upper—Doxorubicin—muscle cancer	0.00111	0.00257	CcSEcCtD
Bromocriptine—HTR2B—vagina—muscle cancer	0.0011	0.0176	CbGeAlD
Bromocriptine—Anorexia—Etoposide—muscle cancer	0.0011	0.00254	CcSEcCtD
Bromocriptine—HTR1D—head—muscle cancer	0.00109	0.0175	CbGeAlD
Bromocriptine—Diarrhoea—Dactinomycin—muscle cancer	0.00109	0.00252	CcSEcCtD
Bromocriptine—Nasopharyngitis—Doxorubicin—muscle cancer	0.00109	0.00252	CcSEcCtD
Bromocriptine—Drowsiness—Methotrexate—muscle cancer	0.00108	0.00251	CcSEcCtD
Bromocriptine—HTR2C—head—muscle cancer	0.00108	0.0173	CbGeAlD
Bromocriptine—Hypotension—Etoposide—muscle cancer	0.00108	0.00249	CcSEcCtD
Bromocriptine—HTR2A—embryo—muscle cancer	0.00107	0.0171	CbGeAlD
Bromocriptine—ADRA2C—cardiac atrium—muscle cancer	0.00107	0.0171	CbGeAlD
Bromocriptine—ADRB1—head—muscle cancer	0.00106	0.017	CbGeAlD
Bromocriptine—Dysphagia—Doxorubicin—muscle cancer	0.00105	0.00243	CcSEcCtD
Bromocriptine—Influenza—Doxorubicin—muscle cancer	0.00105	0.00243	CcSEcCtD
Bromocriptine—CYP1A2—renal system—muscle cancer	0.00104	0.0166	CbGeAlD
Bromocriptine—Paraesthesia—Etoposide—muscle cancer	0.00104	0.0024	CcSEcCtD
Bromocriptine—Dyspnoea—Etoposide—muscle cancer	0.00103	0.00238	CcSEcCtD
Bromocriptine—Somnolence—Etoposide—muscle cancer	0.00103	0.00237	CcSEcCtD
Bromocriptine—Asthenia—Vincristine—muscle cancer	0.00102	0.00236	CcSEcCtD
Bromocriptine—HTR2B—head—muscle cancer	0.00102	0.0162	CbGeAlD
Bromocriptine—HTR7—tendon—muscle cancer	0.00102	0.0162	CbGeAlD
Bromocriptine—Vomiting—Dactinomycin—muscle cancer	0.00101	0.00234	CcSEcCtD
Bromocriptine—Rash—Dactinomycin—muscle cancer	0.00101	0.00232	CcSEcCtD
Bromocriptine—Decreased appetite—Etoposide—muscle cancer	0.001	0.00232	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Etoposide—muscle cancer	0.000997	0.0023	CcSEcCtD
Bromocriptine—Fatigue—Etoposide—muscle cancer	0.000995	0.0023	CcSEcCtD
Bromocriptine—Constipation—Etoposide—muscle cancer	0.000987	0.00228	CcSEcCtD
Bromocriptine—Diarrhoea—Vincristine—muscle cancer	0.000975	0.00225	CcSEcCtD
Bromocriptine—Pollakiuria—Doxorubicin—muscle cancer	0.000973	0.00225	CcSEcCtD
Bromocriptine—Feeling abnormal—Etoposide—muscle cancer	0.000951	0.0022	CcSEcCtD
Bromocriptine—Nausea—Dactinomycin—muscle cancer	0.000948	0.00219	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Etoposide—muscle cancer	0.000944	0.00218	CcSEcCtD
Bromocriptine—Dizziness—Vincristine—muscle cancer	0.000942	0.00218	CcSEcCtD
Bromocriptine—Drowsiness—Doxorubicin—muscle cancer	0.000939	0.00217	CcSEcCtD
Bromocriptine—Visual impairment—Methotrexate—muscle cancer	0.000938	0.00217	CcSEcCtD
Bromocriptine—ADRA2C—tendon—muscle cancer	0.000934	0.0149	CbGeAlD
Bromocriptine—Urticaria—Etoposide—muscle cancer	0.000917	0.00212	CcSEcCtD
Bromocriptine—Abdominal pain—Etoposide—muscle cancer	0.000913	0.00211	CcSEcCtD
Bromocriptine—Body temperature increased—Etoposide—muscle cancer	0.000913	0.00211	CcSEcCtD
Bromocriptine—HTR1A—head—muscle cancer	0.000911	0.0145	CbGeAlD
Bromocriptine—Eye disorder—Methotrexate—muscle cancer	0.00091	0.0021	CcSEcCtD
Bromocriptine—Tinnitus—Methotrexate—muscle cancer	0.000908	0.0021	CcSEcCtD
Bromocriptine—Vomiting—Vincristine—muscle cancer	0.000906	0.00209	CcSEcCtD
Bromocriptine—Cardiac disorder—Methotrexate—muscle cancer	0.000903	0.00209	CcSEcCtD
Bromocriptine—Rash—Vincristine—muscle cancer	0.000899	0.00208	CcSEcCtD
Bromocriptine—Dermatitis—Vincristine—muscle cancer	0.000898	0.00207	CcSEcCtD
Bromocriptine—Headache—Vincristine—muscle cancer	0.000893	0.00206	CcSEcCtD
Bromocriptine—Angiopathy—Methotrexate—muscle cancer	0.000883	0.00204	CcSEcCtD
Bromocriptine—Sinusitis—Doxorubicin—muscle cancer	0.000881	0.00204	CcSEcCtD
Bromocriptine—Mediastinal disorder—Methotrexate—muscle cancer	0.000877	0.00203	CcSEcCtD
Bromocriptine—HTR7—head—muscle cancer	0.000871	0.0139	CbGeAlD
Bromocriptine—ADRA2C—vagina—muscle cancer	0.000866	0.0138	CbGeAlD
Bromocriptine—Alopecia—Methotrexate—muscle cancer	0.00086	0.00199	CcSEcCtD
Bromocriptine—Bradycardia—Doxorubicin—muscle cancer	0.000858	0.00198	CcSEcCtD
Bromocriptine—ADRA2A—cardiac atrium—muscle cancer	0.000855	0.0136	CbGeAlD
Bromocriptine—Mental disorder—Methotrexate—muscle cancer	0.000853	0.00197	CcSEcCtD
Bromocriptine—Nausea—Vincristine—muscle cancer	0.000847	0.00196	CcSEcCtD
Bromocriptine—Rhinitis—Doxorubicin—muscle cancer	0.000845	0.00195	CcSEcCtD
Bromocriptine—HTR2A—smooth muscle tissue—muscle cancer	0.000843	0.0135	CbGeAlD
Bromocriptine—HTR7—testis—muscle cancer	0.000841	0.0134	CbGeAlD
Bromocriptine—ADRA1A—head—muscle cancer	0.00084	0.0134	CbGeAlD
Bromocriptine—Hypoaesthesia—Doxorubicin—muscle cancer	0.000839	0.00194	CcSEcCtD
Bromocriptine—Oedema peripheral—Doxorubicin—muscle cancer	0.00083	0.00192	CcSEcCtD
Bromocriptine—Dysgeusia—Methotrexate—muscle cancer	0.00083	0.00192	CcSEcCtD
Bromocriptine—Asthenia—Etoposide—muscle cancer	0.000828	0.00191	CcSEcCtD
Bromocriptine—Connective tissue disorder—Doxorubicin—muscle cancer	0.000828	0.00191	CcSEcCtD
Bromocriptine—DRD2—head—muscle cancer	0.000823	0.0131	CbGeAlD
Bromocriptine—Visual impairment—Doxorubicin—muscle cancer	0.000812	0.00188	CcSEcCtD
Bromocriptine—HTR2A—renal system—muscle cancer	0.000812	0.013	CbGeAlD
Bromocriptine—ADRA2C—head—muscle cancer	0.0008	0.0128	CbGeAlD
Bromocriptine—Vision blurred—Methotrexate—muscle cancer	0.000799	0.00185	CcSEcCtD
Bromocriptine—DRD2—testis—muscle cancer	0.000795	0.0127	CbGeAlD
Bromocriptine—Diarrhoea—Etoposide—muscle cancer	0.00079	0.00183	CcSEcCtD
Bromocriptine—Eye disorder—Doxorubicin—muscle cancer	0.000788	0.00182	CcSEcCtD
Bromocriptine—Tinnitus—Doxorubicin—muscle cancer	0.000786	0.00182	CcSEcCtD
Bromocriptine—Cardiac disorder—Doxorubicin—muscle cancer	0.000782	0.00181	CcSEcCtD
Bromocriptine—ADRA2C—testis—muscle cancer	0.000773	0.0123	CbGeAlD
Bromocriptine—Angiopathy—Doxorubicin—muscle cancer	0.000765	0.00177	CcSEcCtD
Bromocriptine—Dizziness—Etoposide—muscle cancer	0.000763	0.00176	CcSEcCtD
Bromocriptine—Vertigo—Methotrexate—muscle cancer	0.000761	0.00176	CcSEcCtD
Bromocriptine—Mediastinal disorder—Doxorubicin—muscle cancer	0.00076	0.00176	CcSEcCtD
Bromocriptine—Arrhythmia—Doxorubicin—muscle cancer	0.000753	0.00174	CcSEcCtD
Bromocriptine—CYP3A4—renal system—muscle cancer	0.000751	0.012	CbGeAlD
Bromocriptine—ADRA2A—tendon—muscle cancer	0.000745	0.0119	CbGeAlD
Bromocriptine—Alopecia—Doxorubicin—muscle cancer	0.000745	0.00172	CcSEcCtD
Bromocriptine—Mental disorder—Doxorubicin—muscle cancer	0.000738	0.00171	CcSEcCtD
Bromocriptine—Convulsion—Methotrexate—muscle cancer	0.000734	0.0017	CcSEcCtD
Bromocriptine—Vomiting—Etoposide—muscle cancer	0.000734	0.0017	CcSEcCtD
Bromocriptine—Rash—Etoposide—muscle cancer	0.000728	0.00168	CcSEcCtD
Bromocriptine—Dermatitis—Etoposide—muscle cancer	0.000727	0.00168	CcSEcCtD
Bromocriptine—Headache—Etoposide—muscle cancer	0.000723	0.00167	CcSEcCtD
Bromocriptine—Tension—Doxorubicin—muscle cancer	0.00072	0.00166	CcSEcCtD
Bromocriptine—Dysgeusia—Doxorubicin—muscle cancer	0.000719	0.00166	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000716	0.00166	CcSEcCtD
Bromocriptine—Nervousness—Doxorubicin—muscle cancer	0.000713	0.00165	CcSEcCtD
Bromocriptine—Muscle spasms—Doxorubicin—muscle cancer	0.000705	0.00163	CcSEcCtD
Bromocriptine—ABCB1—embryo—muscle cancer	0.000703	0.0112	CbGeAlD
Bromocriptine—Confusional state—Methotrexate—muscle cancer	0.000697	0.00161	CcSEcCtD
Bromocriptine—Vision blurred—Doxorubicin—muscle cancer	0.000691	0.0016	CcSEcCtD
Bromocriptine—ADRA2A—vagina—muscle cancer	0.000691	0.011	CbGeAlD
Bromocriptine—Infection—Methotrexate—muscle cancer	0.000687	0.00159	CcSEcCtD
Bromocriptine—Nausea—Etoposide—muscle cancer	0.000686	0.00158	CcSEcCtD
Bromocriptine—Nervous system disorder—Methotrexate—muscle cancer	0.000678	0.00157	CcSEcCtD
Bromocriptine—Agitation—Doxorubicin—muscle cancer	0.000674	0.00156	CcSEcCtD
Bromocriptine—Skin disorder—Methotrexate—muscle cancer	0.000672	0.00155	CcSEcCtD
Bromocriptine—Vertigo—Doxorubicin—muscle cancer	0.000659	0.00152	CcSEcCtD
Bromocriptine—Anorexia—Methotrexate—muscle cancer	0.000659	0.00152	CcSEcCtD
Bromocriptine—Syncope—Doxorubicin—muscle cancer	0.000658	0.00152	CcSEcCtD
Bromocriptine—Hypotension—Methotrexate—muscle cancer	0.000646	0.00149	CcSEcCtD
Bromocriptine—Loss of consciousness—Doxorubicin—muscle cancer	0.000645	0.00149	CcSEcCtD
Bromocriptine—ADRA2A—head—muscle cancer	0.000639	0.0102	CbGeAlD
Bromocriptine—Convulsion—Doxorubicin—muscle cancer	0.000636	0.00147	CcSEcCtD
Bromocriptine—Hypertension—Doxorubicin—muscle cancer	0.000633	0.00146	CcSEcCtD
Bromocriptine—HTR2A—tendon—muscle cancer	0.000633	0.0101	CbGeAlD
Bromocriptine—Insomnia—Methotrexate—muscle cancer	0.000625	0.00145	CcSEcCtD
Bromocriptine—Anxiety—Doxorubicin—muscle cancer	0.000622	0.00144	CcSEcCtD
Bromocriptine—Paraesthesia—Methotrexate—muscle cancer	0.000621	0.00143	CcSEcCtD
Bromocriptine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.00062	0.00143	CcSEcCtD
Bromocriptine—ADRA2A—testis—muscle cancer	0.000617	0.00985	CbGeAlD
Bromocriptine—Dyspnoea—Methotrexate—muscle cancer	0.000617	0.00142	CcSEcCtD
Bromocriptine—Somnolence—Methotrexate—muscle cancer	0.000615	0.00142	CcSEcCtD
Bromocriptine—Dry mouth—Doxorubicin—muscle cancer	0.000611	0.00141	CcSEcCtD
Bromocriptine—Dyspepsia—Methotrexate—muscle cancer	0.000609	0.00141	CcSEcCtD
Bromocriptine—Confusional state—Doxorubicin—muscle cancer	0.000604	0.0014	CcSEcCtD
Bromocriptine—Decreased appetite—Methotrexate—muscle cancer	0.000601	0.00139	CcSEcCtD
Bromocriptine—Oedema—Doxorubicin—muscle cancer	0.000599	0.00138	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000597	0.00138	CcSEcCtD
Bromocriptine—Fatigue—Methotrexate—muscle cancer	0.000596	0.00138	CcSEcCtD
Bromocriptine—Infection—Doxorubicin—muscle cancer	0.000595	0.00137	CcSEcCtD
Bromocriptine—Shock—Doxorubicin—muscle cancer	0.000589	0.00136	CcSEcCtD
Bromocriptine—HTR2A—vagina—muscle cancer	0.000588	0.00938	CbGeAlD
Bromocriptine—Nervous system disorder—Doxorubicin—muscle cancer	0.000587	0.00136	CcSEcCtD
Bromocriptine—Tachycardia—Doxorubicin—muscle cancer	0.000584	0.00135	CcSEcCtD
Bromocriptine—Skin disorder—Doxorubicin—muscle cancer	0.000582	0.00134	CcSEcCtD
Bromocriptine—Anorexia—Doxorubicin—muscle cancer	0.000571	0.00132	CcSEcCtD
Bromocriptine—Feeling abnormal—Methotrexate—muscle cancer	0.00057	0.00132	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000565	0.00131	CcSEcCtD
Bromocriptine—Hypotension—Doxorubicin—muscle cancer	0.00056	0.00129	CcSEcCtD
Bromocriptine—Urticaria—Methotrexate—muscle cancer	0.000549	0.00127	CcSEcCtD
Bromocriptine—Abdominal pain—Methotrexate—muscle cancer	0.000547	0.00126	CcSEcCtD
Bromocriptine—Body temperature increased—Methotrexate—muscle cancer	0.000547	0.00126	CcSEcCtD
Bromocriptine—HTR2A—head—muscle cancer	0.000543	0.00867	CbGeAlD
Bromocriptine—Insomnia—Doxorubicin—muscle cancer	0.000542	0.00125	CcSEcCtD
Bromocriptine—Paraesthesia—Doxorubicin—muscle cancer	0.000538	0.00124	CcSEcCtD
Bromocriptine—Dyspnoea—Doxorubicin—muscle cancer	0.000534	0.00123	CcSEcCtD
Bromocriptine—Somnolence—Doxorubicin—muscle cancer	0.000532	0.00123	CcSEcCtD
Bromocriptine—ABCB1—renal system—muscle cancer	0.000532	0.00849	CbGeAlD
Bromocriptine—Dyspepsia—Doxorubicin—muscle cancer	0.000527	0.00122	CcSEcCtD
Bromocriptine—HTR2A—testis—muscle cancer	0.000525	0.00837	CbGeAlD
Bromocriptine—Decreased appetite—Doxorubicin—muscle cancer	0.000521	0.0012	CcSEcCtD
Bromocriptine—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000517	0.00119	CcSEcCtD
Bromocriptine—Fatigue—Doxorubicin—muscle cancer	0.000516	0.00119	CcSEcCtD
Bromocriptine—Constipation—Doxorubicin—muscle cancer	0.000512	0.00118	CcSEcCtD
Bromocriptine—Asthenia—Methotrexate—muscle cancer	0.000496	0.00115	CcSEcCtD
Bromocriptine—Feeling abnormal—Doxorubicin—muscle cancer	0.000493	0.00114	CcSEcCtD
Bromocriptine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00049	0.00113	CcSEcCtD
Bromocriptine—Urticaria—Doxorubicin—muscle cancer	0.000476	0.0011	CcSEcCtD
Bromocriptine—Abdominal pain—Doxorubicin—muscle cancer	0.000473	0.00109	CcSEcCtD
Bromocriptine—Body temperature increased—Doxorubicin—muscle cancer	0.000473	0.00109	CcSEcCtD
Bromocriptine—Diarrhoea—Methotrexate—muscle cancer	0.000473	0.00109	CcSEcCtD
Bromocriptine—Dizziness—Methotrexate—muscle cancer	0.000457	0.00106	CcSEcCtD
Bromocriptine—Vomiting—Methotrexate—muscle cancer	0.00044	0.00102	CcSEcCtD
Bromocriptine—Rash—Methotrexate—muscle cancer	0.000436	0.00101	CcSEcCtD
Bromocriptine—Dermatitis—Methotrexate—muscle cancer	0.000436	0.00101	CcSEcCtD
Bromocriptine—Headache—Methotrexate—muscle cancer	0.000433	0.001	CcSEcCtD
Bromocriptine—Asthenia—Doxorubicin—muscle cancer	0.00043	0.000993	CcSEcCtD
Bromocriptine—Nausea—Methotrexate—muscle cancer	0.000411	0.000949	CcSEcCtD
Bromocriptine—Diarrhoea—Doxorubicin—muscle cancer	0.00041	0.000947	CcSEcCtD
Bromocriptine—ABCB1—bone marrow—muscle cancer	0.000402	0.00642	CbGeAlD
Bromocriptine—Dizziness—Doxorubicin—muscle cancer	0.000396	0.000915	CcSEcCtD
Bromocriptine—ABCB1—vagina—muscle cancer	0.000385	0.00615	CbGeAlD
Bromocriptine—Vomiting—Doxorubicin—muscle cancer	0.000381	0.00088	CcSEcCtD
Bromocriptine—Rash—Doxorubicin—muscle cancer	0.000378	0.000872	CcSEcCtD
Bromocriptine—Dermatitis—Doxorubicin—muscle cancer	0.000377	0.000872	CcSEcCtD
Bromocriptine—Headache—Doxorubicin—muscle cancer	0.000375	0.000867	CcSEcCtD
Bromocriptine—ABCB1—head—muscle cancer	0.000356	0.00568	CbGeAlD
Bromocriptine—Nausea—Doxorubicin—muscle cancer	0.000356	0.000822	CcSEcCtD
Bromocriptine—ABCB1—testis—muscle cancer	0.000344	0.00549	CbGeAlD
